Treatment of Fluoroquinolone-Associated Achilles Tendon Tendinopathy
The primary treatment for fluoroquinolone-associated Achilles tendinopathy includes immediate discontinuation of the fluoroquinolone antibiotic, rest, non-steroidal anti-inflammatory drugs, physical modalities, and a progressive rehabilitation program with eccentric strengthening exercises. 1
Immediate Management
- Discontinue fluoroquinolone use immediately at the first sign of tendon inflammation to reduce the risk of progression to tendon rupture 1, 2
- Rest and reduce stress on the tendon through the use of assistive devices such as crutches during the acute phase 3
- Consider orthoses or bracing to offload the affected tendon during the initial healing phase 3
- Use non-steroidal anti-inflammatory drugs (NSAIDs) for pain management during the acute inflammatory phase 1
Antioxidant Supplementation
- Consider magnesium supplementation during the treatment course if no contraindications exist, as recommended by the American College of Physical Medicine and Rehabilitation 4
- Antioxidant supplementation with vitamin E or coenzyme Q10 may be beneficial based on preliminary data showing protective effects against fluoroquinolone-induced tendon damage 5
- Mitochondrial-targeted ubiquinone (MitoQ) has demonstrated larger protective effects than untargeted ubiquinone in human Achilles tendon cells exposed to fluoroquinolones 5
Rehabilitation Protocol
Implement a two-phase rehabilitation approach based on connective tissue remodeling principles 3:
Incorporate eccentric strengthening exercises as the cornerstone of rehabilitation once the acute phase has resolved 1
Gradually progress physical activity based on pain response and functional improvement 3
Monitoring and Follow-up
- Monitor for symptom improvement - most patients report recovery within 2 months of discontinuing the fluoroquinolone antibiotic, though 26% may still report pain and disability at follow-up 5
- Consider MRI imaging to distinguish between tendinitis and partial tendon rupture if symptoms persist or worsen despite appropriate management 2
- Refer for surgical consultation if tendon rupture occurs or is suspected 1, 6
Special Considerations and Risk Factors
- Higher vigilance is needed for patients over 60 years who have 4 times higher risk of Achilles tendon rupture compared to the general population 7
- Concomitant corticosteroid use dramatically increases risk (odds ratio 43.2 for Achilles tendon rupture) and may require more aggressive management 7, 4
- Athletes and physically active individuals require special attention as 50% of fluoroquinolone-associated tendon disorders occur during sports participation 5
- Bilateral involvement is common, occurring in more than half of cases, necessitating comprehensive assessment of both Achilles tendons 5
Pitfalls and Caveats
- Do not delay discontinuation of the fluoroquinolone - symptoms can occur as early as 2 hours after initial exposure or as late as 6 months after discontinuation 5, 7
- Avoid corticosteroid injections which may further increase the risk of tendon rupture 7
- Do not rush return to full activity as premature loading may lead to tendon rupture 3
- Be aware that other tendons may be affected beyond the Achilles, including patellar tendon, rotator cuff, and various hand and foot tendons 5, 7